- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03833791
Effect of Different Physical Programs on the Body Composition of Adult Men and Women With an Initial Body Fat >25% and >30%, Respectively.
Effect of the Prescription of Physical Activity on the Fat, Muscle Mass, and Body Weight of Overweight or Adult Men and Women: Randomized Clinical Trial of 6 Month Duration.
Study Overview
Status
Conditions
Detailed Description
Weight loss by exercise can be frequently deceptive. The focus continues to be centred around total body weight and body mass index (BMI), despite the fact that body fat and fat-free mass are the indicators that represent the greatest risk in the comorbidity associated with obesity. Body weight per se cannot be considered to be reliable; however, its quality can be justified, when measured together with the loss in body fat and the maintenance or increase in fat-free mass.
The purpose of the study is compare the effect of different physical programs (FA) on the body composition (BC) of adult women with a total body fat percentage ≥ 30 % and adult men with a BMI ≥25 at the beginning of the test.
Participants (n=220, women = 110, men = 110) will be recruited through outpatient from private clinics in Cádiz, Andalucía, Spain, as well as through community presentations. Overweight or obese and sedentary women and men will be randomly assigned into three groups according to different levels of AF. 21 of the participants will be assigned to the sedentary control group (METs <2.9), 20 in a group of moderate AF (METs 3-5.9), and 19 will be assigned to the group of intense AF (METs >6).
For 6 months, all of the women shall follow the same diet with an identical distribution of macronutrients. There will be a weekly check up of weight, fat, body water and muscle mass for all of them.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Having a body fat percentage >30
- Having a BMI >25
- Being sedentary and
- Have not been submitted to a restrictive diet in the 6 months preceding this study.
Exclusion Criteria:
- Suffered from type 2 diabetes or renal conditions
- Being pregnancy or attempt at pregnancy,
- Being in a maternal lactation period,
- Being underage
- Undergoing antidepressant pharmacological treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control Group (CON)
education and modifying diet
|
The control group maintains a sedentary lifestyle and is only subjected to follow a hypocaloric diet
|
Experimental: Moderate physical activity Group (PAM)
education, modifying diet and physical activity prescription
|
One group, in addition to fulfilling a hypocaloric diet identical to the control group, is subjected to prescribe moderate physical activity. Other group, in addition to fulfilling a hypocaloric diet identical to the control and moderate group, is subjected to prescribe intense activity. |
Experimental: Intensity physical activity Group (PAI)
education, modifying diet and physical activity prescription
|
One group, in addition to fulfilling a hypocaloric diet identical to the control group, is subjected to prescribe moderate physical activity. Other group, in addition to fulfilling a hypocaloric diet identical to the control and moderate group, is subjected to prescribe intense activity. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes from baseline BMI.
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean BMI values will be measured and compared at 3, 6, 12 and 24 months.
BMI will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
|
At baseline (0 years) and followed for 2 years
|
Changes from baseline Fatty mass.
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Fatty mass values will be measured and compared at 3, 6, 12 and 24 months.
Fatty mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a percentage.
|
At baseline (0 years) and followed for 2 years
|
Changes from baseline Free-fatty mass.
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Free-fatty mass values will be measured and compared at 3, 6, 12 and 24 months.
Free-fatty mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a percentage.
|
At baseline (0 years) and followed for 2 years
|
Changes from baseline Muscular Mass.
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Muscular Mass values will be measured and compared at 3, 6, 12 and 24 months.
Muscular Mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a Kg.
|
At baseline (0 years) and followed for 2 years
|
Changes from baseline Corporal Water .
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Corporal Water values will be measured and compared at 3, 6, 12 and 24 months.
Corporal Water will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a Kg.
|
At baseline (0 years) and followed for 2 years
|
Adherence to dietary pattern will be also measured through personal interview
Time Frame: At baseline (0 years) and followed for 2 years
|
Participants will be subjected for an intervention based on nutritional (control group) and physical education (two intervention arms) during 24 months.
Partial measures will be also taken every week.
In the end of the trial, changes in dietary patterns will be measured comparing means differences between baselines, 3, 6, 12 and 24 months.
|
At baseline (0 years) and followed for 2 years
|
Adherence to physical activity patterns will be also measured through IPAQ (International Physical Activity Questionnaire).
Time Frame: At baseline (0 years) and followed for 2 years
|
Participants will be subjected for an intervention based on nutritional (control group) and physical education (two intervention arms) during 24 months.
Partial measures will be also taken every week.
In the end of the trial, changes in physical activity will be measured comparing means differences between baselines, 3, 6, 12 and 24 months.
|
At baseline (0 years) and followed for 2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alberto Hernández-Reyes, Universidad de Córdoba
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TESIS-OBESITICS-2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on education and modifying diet
-
Johns Hopkins Bloomberg School of Public HealthWellness International, Ltd.Terminated
-
Seoul National University HospitalChunLabUnknown
-
The University of Texas Medical Branch, GalvestonTerminatedObesity | Insulin Sensitivity | Postpartum Weight RetentionUnited States
-
University of Kansas Medical CenterNot yet recruitingObesity | Alzheimer Disease | Down SyndromeUnited States
-
Kaiser PermanenteCompleted
-
Dilan aktepe coşarCompleted
-
Boston Children's HospitalUniversity of South Florida; Indiana UniversityNot yet recruitingDiabetes Mellitus, Type 1
-
Rutgers, The State University of New JerseyWithdrawn
-
Stanford UniversityNot yet recruitingColorectal Cancer | Diet, HealthyUnited States
-
Boston Children's HospitalNot yet recruitingCeliac Disease in Children | Nutrition Disorder, ChildUnited States